rs2282679 Genotype/Allele | Cases N(%) | Controls N(%) | OR (95% CI)a | OR (95% CI)b |
---|---|---|---|---|
All cases vs. controls | Â | Â | Â | Â |
 AA | 309 (48.5) | 245 (50.1) | 1.00 | 1.00 |
 AC | 282 (44.3) | 208 (42.5) | 1.08 (0.82–1.41) | 1.10 (0.83–1.47) |
 CC | 46 (7.2) | 36 (7.4) | 1.06 (0.63–1.77) | 1.21 (0.70–2.09) |
 P trendc |  |  | 0.647 | 0.403 |
 CC + AC (vs. AA) | 328 (51.5) | 244 (49.9) | 1.07 (0.83–1.39) | 1.12 (0.85–1.47) |
 CC (vs. AC + AA) | 46 (7.2) | 36 (7.4) | 1.02 (0.62–1.68) | 1.15 (0.68–1.97) |
 Per C allele |  |  | 1.05 (0.85–1.29) | 1.10 (0.88–1.37) |
BRAF V600E mutant cases vs. controls | Â | Â | Â | |
 AA | 25 (46.3) | 245 (50.1) | 1.00 | 1.00 |
 CC + ACd | 29 (53.7) | 244 (49.9) | 1.03 (0.54–1.96) | 1.10 (0.56–2.16) |
BRAF wild-type cases vs. controls | Â | Â | Â | |
 AA | 223 (50.1) | 245 (50.1) | 1.00 | 1.00 |
 CC + ACd | 222 (49.9) | 244 (49.9) | 1.08 (0.82–1.42) | 1.10 (0.82–1.47) |
MSI-H cases vs. controls | Â | Â | Â | Â |
 AA | 31 (50.8) | 245 (50.1) | 1.00 | 1.00 |
 CC + ACd | 30 (49.2) | 244 (49.9) | 0.99 (0.56–1.80) | 1.03 (0.56–1.90) |
MSS/MSI-Low cases vs. controls | Â | Â | Â | |
 AA | 223 (50.0) | 245 (50.1) | 1.00 | 1.00 |
 CC + ACd | 223 (50.0) | 244 (49.9) | 1.09 (0.83–1.44) | 1.15 (0.86–1.53) |